SAN FRANCISCO, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Excision BioTherapeutics, Inc. ("Excision", the "Company"), a clinical-stage biotechnology company developing CRISPR-based therapies to cure serious ...
Cold sores may play a role in the development of Alzheimer’s disease, according to a new study published in BMJ Open. Researchers examined 344,628 "case-control pairs." The pairs were matched in age, ...
Theralase® validates previous University of Manitoba research by demonstrating that RuvidarTM is safe and effective in the treatment of the Herpes Simplex Virus in an animal model. TORONTO, ON / ...
PITTSBURGH, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS) announced today that the United States Food and Drug Administration (FDA) granted platform technology ...
— Dr. David Ginn, Senior VP of Research and Development at Erroll McCoy AUGUSTA, GA, UNITED STATES, December 12, 2024 /EINPresswire.com/ -- Erroll McCoy is excited ...
“To completely cure HSV-1, the idea is to prevent the virus from going into latency, because then, it’s protected by our own bodies,” said Esther González-Almela, a virologist at the Guangdong Academy ...
- Excision’s proprietary gene editing technology holds unique, curative potential to address the leading cause of corneal blindness in the United States - Global incidence of HSV keratitis is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback